China Pharma Holdings
CPHI
5 hedge funds and large institutions have $368K invested in China Pharma Holdings in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
59% more capital invested
Capital invested by funds: $231K → $368K (+$137K)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
44% less funds holding
Funds holding: 9 → 5 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$82K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$63.3K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$3.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26K |
| 2 |
VF
Virtu Financial
New York
|
-$25K |
| 3 |
Jane Street
New York
|
-$10K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.68K |
CPHI Hedge Fund Activity: Q1 2019 in Review
5 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2019, worth a combined $368K — up 59% from $231K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CPHI and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $82K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $26K sold.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q1 2019, down from 9 in Q4 2018.
- Funds reported $368K of China Pharma Holdings stock for Q1 2019, up 59% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q1 2019 and 5 closed out, a net change of -4 holders.
- The largest China Pharma Holdings buyer in Q1 2019 was Renaissance Technologies, an estimated $82K added.
- The largest China Pharma Holdings seller in Q1 2019 was Susquehanna International Group, an estimated $26K sold.
Based on aggregated 13F filings for Q1 2019.